-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
BRO posted Q1 2026 adjusted EPS of $1.39 versus $1.29, modestly topping our $1.37 estimate and the $1.36 consensus view, though revenue growth of 35% to $1.9B was acquisition-driven with $435M from deals. Organic revenues were flat Y/Y at $1.35B, lagging our 4% to 8% growth forecast, while Q1 EBIT margins contracted to 28.0% from 30.4% due to acquisition costs and doubled interest expense. We believe the shares lack a near-term catalyst given below-peer organic growth rates and margin compression that removes BRO's historical premium valuation justification. Management characterized business conditions as "challenging," representing a shift from last quarter's "stable" assessment. BRO completed 43 acquisitions in 2025, including the $9.8B Accession deal, and we expect acquisitions to remain central to growth strategy as organic growth slows. In our view, the combination of flat organic growth and margin contraction will pressure the shares' premium valuation to peers.